Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Dialysis | 11 | 2017 | 131 | 2.260 |
Why?
|
| Kidney Failure, Chronic | 13 | 2017 | 242 | 1.560 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2026 | 193 | 1.360 |
Why?
|
| Referral and Consultation | 2 | 2026 | 142 | 1.100 |
Why?
|
| Nephrology | 2 | 2026 | 20 | 1.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 89 | 0.540 |
Why?
|
| Hypernatremia | 1 | 2017 | 10 | 0.520 |
Why?
|
| Electric Conductivity | 1 | 2017 | 55 | 0.520 |
Why?
|
| Aged | 20 | 2026 | 8214 | 0.470 |
Why?
|
| Ambulatory Care Facilities | 2 | 2014 | 68 | 0.440 |
Why?
|
| Population Groups | 2 | 2014 | 59 | 0.420 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 749 | 0.410 |
Why?
|
| Middle Aged | 25 | 2026 | 12222 | 0.400 |
Why?
|
| Appointments and Schedules | 2 | 2014 | 32 | 0.370 |
Why?
|
| Patient Compliance | 1 | 2014 | 233 | 0.370 |
Why?
|
| Glomerular Filtration Rate | 4 | 2008 | 147 | 0.370 |
Why?
|
| Catheters, Indwelling | 2 | 2003 | 10 | 0.360 |
Why?
|
| Nephrosclerosis | 3 | 2002 | 8 | 0.360 |
Why?
|
| Retrospective Studies | 7 | 2026 | 2544 | 0.360 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2003 | 5 | 0.340 |
Why?
|
| Heart Failure | 2 | 2007 | 302 | 0.340 |
Why?
|
| Male | 26 | 2026 | 23409 | 0.320 |
Why?
|
| Proteinuria | 2 | 2002 | 56 | 0.320 |
Why?
|
| Kidney Diseases | 4 | 2008 | 172 | 0.320 |
Why?
|
| Thrombosis | 2 | 2003 | 81 | 0.310 |
Why?
|
| Adult | 19 | 2026 | 13872 | 0.300 |
Why?
|
| Humans | 30 | 2026 | 43102 | 0.280 |
Why?
|
| Coronary Disease | 2 | 2010 | 123 | 0.280 |
Why?
|
| Treatment Refusal | 1 | 2008 | 23 | 0.280 |
Why?
|
| Aged, 80 and over | 7 | 2017 | 2853 | 0.270 |
Why?
|
| Female | 23 | 2026 | 24698 | 0.260 |
Why?
|
| Urban Population | 2 | 2026 | 374 | 0.250 |
Why?
|
| Albuminuria | 1 | 2026 | 78 | 0.230 |
Why?
|
| Troponin T | 1 | 2004 | 10 | 0.220 |
Why?
|
| Feasibility Studies | 1 | 2026 | 259 | 0.220 |
Why?
|
| Hospitalization | 3 | 2014 | 485 | 0.220 |
Why?
|
| Serum Albumin | 2 | 2005 | 59 | 0.210 |
Why?
|
| Pilot Projects | 1 | 2026 | 760 | 0.190 |
Why?
|
| Hyperkalemia | 1 | 2002 | 13 | 0.190 |
Why?
|
| Diuretics | 1 | 2002 | 51 | 0.190 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 78 | 0.190 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2003 | 77 | 0.190 |
Why?
|
| Spironolactone | 1 | 2002 | 36 | 0.180 |
Why?
|
| Warfarin | 1 | 2003 | 67 | 0.180 |
Why?
|
| Hypertension, Renal | 1 | 2002 | 16 | 0.180 |
Why?
|
| Nephrotic Syndrome | 1 | 2002 | 11 | 0.180 |
Why?
|
| Aspirin | 1 | 2003 | 89 | 0.180 |
Why?
|
| Anticoagulants | 1 | 2003 | 122 | 0.180 |
Why?
|
| Risk Factors | 9 | 2010 | 3994 | 0.180 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 1234 | 0.170 |
Why?
|
| Pica | 1 | 2001 | 4 | 0.170 |
Why?
|
| Aluminum Silicates | 1 | 2001 | 7 | 0.170 |
Why?
|
| Hypertension | 4 | 2006 | 835 | 0.160 |
Why?
|
| Disease Progression | 2 | 2018 | 667 | 0.160 |
Why?
|
| Treatment Outcome | 3 | 2018 | 1604 | 0.150 |
Why?
|
| Time Factors | 4 | 2008 | 1857 | 0.150 |
Why?
|
| Vascular Patency | 1 | 1998 | 4 | 0.140 |
Why?
|
| Cholesterol | 1 | 1999 | 232 | 0.140 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 107 | 0.130 |
Why?
|
| Iatrogenic Disease | 1 | 2017 | 7 | 0.130 |
Why?
|
| Regression Analysis | 3 | 2008 | 490 | 0.130 |
Why?
|
| Vitamin D | 1 | 2018 | 196 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2008 | 1600 | 0.120 |
Why?
|
| Survival Analysis | 3 | 2002 | 368 | 0.110 |
Why?
|
| Mass Screening | 2 | 2010 | 541 | 0.110 |
Why?
|
| Georgia | 3 | 2006 | 192 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 19 | 0.100 |
Why?
|
| United States | 5 | 2018 | 5205 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2018 | 1003 | 0.090 |
Why?
|
| Comorbidity | 3 | 2005 | 737 | 0.090 |
Why?
|
| Prevalence | 3 | 2018 | 1612 | 0.090 |
Why?
|
| Indians, North American | 1 | 2014 | 192 | 0.080 |
Why?
|
| Kidney Function Tests | 1 | 2010 | 32 | 0.080 |
Why?
|
| Creatinine | 2 | 2002 | 102 | 0.080 |
Why?
|
| Risk Reduction Behavior | 1 | 2010 | 138 | 0.080 |
Why?
|
| Logistic Models | 2 | 2004 | 1009 | 0.080 |
Why?
|
| Length of Stay | 2 | 2002 | 229 | 0.080 |
Why?
|
| Community Networks | 2 | 2006 | 107 | 0.070 |
Why?
|
| Prognosis | 2 | 2002 | 861 | 0.070 |
Why?
|
| Incidence | 2 | 2002 | 1078 | 0.070 |
Why?
|
| Kidney | 2 | 2002 | 372 | 0.070 |
Why?
|
| Anemia | 2 | 2007 | 55 | 0.070 |
Why?
|
| Infant, Low Birth Weight | 1 | 2007 | 36 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2008 | 263 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2006 | 74 | 0.060 |
Why?
|
| Unemployment | 1 | 2005 | 29 | 0.060 |
Why?
|
| Registries | 2 | 2005 | 437 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 247 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2005 | 120 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2004 | 96 | 0.050 |
Why?
|
| Stroke | 1 | 2008 | 340 | 0.050 |
Why?
|
| Educational Status | 1 | 2005 | 339 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2005 | 226 | 0.050 |
Why?
|
| Education, Medical | 1 | 2005 | 118 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 440 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2003 | 12 | 0.050 |
Why?
|
| Sex Factors | 2 | 2007 | 1028 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2005 | 208 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 269 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2002 | 60 | 0.050 |
Why?
|
| Diabetic Nephropathies | 1 | 2003 | 78 | 0.050 |
Why?
|
| Poverty | 1 | 2005 | 400 | 0.050 |
Why?
|
| Alcoholism | 1 | 2005 | 305 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 234 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 310 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 196 | 0.040 |
Why?
|
| Kidney Tubules | 1 | 2002 | 39 | 0.040 |
Why?
|
| Biopsy | 1 | 2002 | 177 | 0.040 |
Why?
|
| Radiology, Interventional | 1 | 2000 | 3 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2002 | 86 | 0.040 |
Why?
|
| Aluminum | 1 | 2001 | 39 | 0.040 |
Why?
|
| Silicon Dioxide | 1 | 2001 | 39 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2000 | 18 | 0.040 |
Why?
|
| Minerals | 1 | 2001 | 53 | 0.040 |
Why?
|
| Minority Groups | 2 | 2005 | 690 | 0.040 |
Why?
|
| Potassium | 1 | 2001 | 109 | 0.040 |
Why?
|
| Health Promotion | 1 | 2006 | 704 | 0.040 |
Why?
|
| Early Diagnosis | 2 | 2010 | 68 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 706 | 0.040 |
Why?
|
| Iron | 1 | 2001 | 251 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2000 | 518 | 0.040 |
Why?
|
| Age Factors | 1 | 2002 | 1154 | 0.040 |
Why?
|
| Aging | 2 | 2002 | 783 | 0.040 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 1998 | 10 | 0.030 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 1998 | 14 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1998 | 18 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2005 | 830 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2001 | 1285 | 0.030 |
Why?
|
| Health Surveys | 1 | 2018 | 405 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2006 | 666 | 0.030 |
Why?
|
| Adolescent | 2 | 2007 | 6081 | 0.030 |
Why?
|
| Community Health Services | 2 | 2008 | 206 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2008 | 549 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 1998 | 1063 | 0.030 |
Why?
|
| Endothelins | 1 | 1993 | 7 | 0.020 |
Why?
|
| Erythropoietin | 1 | 1993 | 38 | 0.020 |
Why?
|
| Primary Health Care | 2 | 2005 | 380 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2010 | 62 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 1998 | 3156 | 0.020 |
Why?
|
| Foundations | 1 | 2008 | 12 | 0.020 |
Why?
|
| Human Experimentation | 1 | 2008 | 11 | 0.020 |
Why?
|
| South Carolina | 1 | 2006 | 25 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2008 | 341 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 638 | 0.020 |
Why?
|
| North Carolina | 1 | 2006 | 127 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 59 | 0.020 |
Why?
|
| Group Practice | 1 | 2005 | 8 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2007 | 972 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2005 | 110 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 223 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2005 | 161 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 287 | 0.010 |
Why?
|
| Hematocrit | 1 | 1993 | 26 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1993 | 36 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1993 | 67 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1993 | 518 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1993 | 1124 | 0.000 |
Why?
|